Anaphylm (dibutepinephrine)

Name: Anaphylm (dibutepinephrine) in Type I allergic reactions including anaphylaxis: Disease description
Published: 2026-09-21T21:39:21-04:00

Type I allergic reactions including anaphylaxis

Also known as AQST-109

Manufacturer: Aquestive Therapeutics
Regulatory submission: NDA resubmitted September 2026
Launch: Not announced
Last updated: September 21, 2026

Section

Product information and disease description Place of product in therapy

Disease description

102 evidence topics · 59 sources

Definition and etiology11 evidence topics · 6 sources
Epidemiology17 evidence topics · 15 sources
Natural history, survival, and mortality11 evidence topics · 11 sources
Pathophysiology9 evidence topics · 5 sources
Diagnosis14 evidence topics · 8 sources
Clinical presentation - signs and symptoms8 evidence topics · 6 sources
Long-term morbidity8 evidence topics · 8 sources
Burden of Type I allergic reactions including anaphylaxis24 evidence topics · 22 sources